386996915 | PUO | 22149326 | | 0482464 | 5/19/2006 12:00:00 AM | S/P Rt TKR | | DIS | Admission Date: 10/2/2006 Report Status: Discharge Date: 7/5/2006 ****** FINAL DISCHARGE ORDERS ****** CORLETT , DAPHNE NIA 689-20-53-1 Ing Ee Stalin Service: ORT DISCHARGE PATIENT ON: 3/6/06 AT 01:00 PM CONTINGENT UPON Not Applicable WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES Attending: RADEMAN , CAITLIN , M.D. DISPOSITION: Rehabilitation DISCHARGE MEDICATIONS: TYLENOL ( ACETAMINOPHEN ) 650 MG PO Q4H Starting Today ( 3/10 ) PRN Pain , Headache , Other:fever greater than Instructions: Do not exceed 4000mg in 24 hours. 
CALCIUM CARBONATE ( 500 MG ELEMENTAL CA++ ) 500 MG PO DAILY COLACE ( DOCUSATE SODIUM ) 100 MG PO BID FAMOTIDINE 20 MG PO BID INSULIN REGULAR HUMAN Sliding Scale ( subcutaneously ) SC Q6H If BS is less than 125 , then give 0 units subcutaneously If BS is 125-150 , then give 2 units subcutaneously If BS is 151-200 , then give 3 units subcutaneously If BS is 201-250 , then give 4 units subcutaneously If BS is 251-300 , then give 6 units subcutaneously If BS is 301-350 , then give 8 units subcutaneously If BS is 351-400 , then give 10 units subcutaneously and call HO Call HO if BS is greater than 400 LEVOTHYROXINE SODIUM 50 MCG PO DAILY Alert overridden: Override added on 8/23/06 by STIDMAN , GENOVEVA , M.D. SERIOUS INTERACTION: WARFARIN &amp; LEVOTHYROXINE SODIUM Reason for override: will monitor MVI ( MULTIVITAMINS ) 1 TAB PO DAILY Override Notice: Override added on 8/23/06 by STIDMAN , GENOVEVA , M.D. on order for ZOCOR PO ( ref # 752361755 ) POTENTIALLY SERIOUS INTERACTION: NIACIN , VIT. B-3 &amp; SIMVASTATIN Reason for override: will monitor OXYCODONE 5 MG PO Q6H Starting Today ( 3/10 ) PRN Pain HOLD IF: somnolent , mental status changes COUMADIN ( WARFARIN SODIUM ) 6 MG PO x1 Instructions: Dose for 1/7/06. 
Monitor a daily PT/INR in rehab and adjust the dose for a goal INR of 1.5-2.5;DVT 
prophylaxis is planned X 3 weeks Food/Drug Interaction Instruction No high Vitamin-K containing foods Override Notice: Override added on 8/23/06 by STIDMAN , GENOVEVA , M.D. on order for ZOCOR PO ( ref # 752361755 ) POTENTIALLY SERIOUS INTERACTION: WARFARIN &amp; SIMVASTATIN Reason for override: will monitor Previous override information: Override added on 8/23/06 by STIDMAN , GENOVEVA , M.D. on order for LEVOTHYROXINE SODIUM PO ( ref # 767853250 ) SERIOUS INTERACTION: WARFARIN &amp; LEVOTHYROXINE SODIUM Reason for override: will monitor NORVASC ( AMLODIPINE ) 10 MG PO DAILY Starting IN AM ( 3/9 ) HOLD IF: SBP &lt; 110 Food/Drug Interaction Instruction Avoid grapefruit unless MD instructs otherwise. 
METFORMIN 500 MG PO BID Starting when TOLERATING ADA DIET OXYCONTIN ( OXYCODONE CONTROLLED RELEASE ) 10 MG PO Q12H HYZAAR ( 25 MG/100 MG ) ( HYDROCHLORTHIAZIDE 25M... ) 1 TAB PO DAILY Starting IN AM ( 3/9 ) HOLD IF: SBP &lt; 110 Number of Doses Required ( approximate ): 6 ACTOS ( PIOGLITAZONE ) 15 MG PO DAILY Starting when TOLERATING ADA DIET Food/Drug Interaction Instruction May be taken without regard to meals INSULIN NPH HUMAN 42 UNITS SC QAM HOLD IF: NPO FERROUS SULFATE 325 MG PO TID Food/Drug Interaction Instruction Avoid milk and antacid DIET: House / Low chol/low sat. 
fat ACTIVITY: weight bear as tolerated with UE support FOLLOW UP APPOINTMENT( S ): Dr Rademan 4/27/06 Xray at 2:00pm Appt at 3:00pm 3/25/06 , Arrange INR to be drawn on 9/20/06 with f/u INR's to be drawn every MONDAY/THURSDAY days. 
INR's will be followed by PUO Anticoagulation service , 592.004.9708 
ALLERGY: LISINOPRIL ADMIT DIAGNOSIS: OA Rt Knee PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission ) S/P Rt TKR OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay Osteoarthritis , Hypertension , Diabuetes Mellitus , Hypothyroidism OPERATIONS AND PROCEDURES: 8/23/06 RADEMAN , CAITLIN , M.D. RT TKR OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. ) N/A BRIEF RESUME OF HOSPITAL COURSE: Pt underwent a Rt TKR on 6/20/06 for endstage OA. 
The patient tolerated the procedure well , and had an uncomplicated post-operative course on the TKR pathway with exception of post-op delerium which required a sitter for safety on POD 2. Patients MS gradually improved , and returned to baseline by POD 3 , at which time the sitter was discontinued. 
Pt was HD stable with no transfusion requirements during her hospitalization. 
Hct was trending up on POD 4 at 28.7. 
Standard care with PCEA for acute pain management/CPM , prophylactic IV abx , and Coumadin/TEDS/P-boots for DVT prophylaxis. 
Pt mobilized OOB with PT WBAT. 
Refer to the page 3 for ROM/functional details. 
Wound clean and healing at time of discharge. 
Pt stable for transfer to rehab on POD 4. ADDITIONAL COMMENTS: DSD qd. 
The wound may be left OTA when dry. Staples may be removed in rehab or by the VNA as of 2/30/06 , please sterristrip the wound. 
Continue TEDS for DVT prophylaxis. 
When the patient is discharged home , please arrange blood draws for PT/INR q Mon/Thurs with results called to the CKMH Anticoagulation Service he439-008-7022 hki 3 for outpatient anticoagulation management. 
Goal INR is 1.5-2.5;DVT 
prophyalxis is planned X 3 weeks. 
Any outpatient anticoagulation issues or action values should be called to the Anticoagulation Service. 
DISCHARGE CONDITION: Stable TO DO/PLAN: Arrange blood draws for PT/INR q Mon/Thurs with results called to 765-060-3001 jys 9 for outpatient anticoagulation management NOTIFY the Anticoagulation Service when the patient is discharged home Staple removal 7/27/06 Follow up with Dr Rademan as scheduled No dictated summary ENTERED BY: SCOVEL , DULCIE , PA-C ( XP60 ) 3/6/06 @ 12 ****** END OF DISCHARGE ORDERS ******